Status:

UNKNOWN

Evaluation of Stigma and Related Factors in Fibromyalgia

Lead Sponsor:

Gaziosmanpasa Research and Education Hospital

Conditions:

Fibromyalgia

Eligibility:

All Genders

18+ years

Brief Summary

Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in...

Detailed Description

Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in...

Eligibility Criteria

Inclusion

  • Patients over the age of 18
  • To be diagnosed with fibromyalgia according to American College of Rheumatology 2016 revised criteria

Exclusion

  • Have been diagnosed and treated with fibromyalgia before
  • Presence of any diagnosis that can cause secondary fibromyalgia (rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis)
  • The presence of anemia
  • Vitamin D deficiency
  • Presence of known endocrine, neurological and cardiac diseases
  • Antidepressant use

Key Trial Info

Start Date :

February 13 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2020

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT04274036

Start Date

February 13 2020

End Date

May 31 2020

Last Update

February 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gaziosmanpasa Taksim Research and Education Hospital

Istanbul, Turkey (Türkiye)